BORTEZOMIB KABI POWDER FOR SOLUTION FOR INJECTION 3.5MG/VIAL Medication Singapore | Medicine SG
BORTEZOMIB KABI POWDER FOR SOLUTION FOR INJECTION 3.5MG/VIAL is a medication in Singapore. The dosage in INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION form, is administered by the SUBCUTANEOUS or INTRAVENOUS BOLUS route. The licence is held by FRESENIUS KABI (SINGAPORE) PTE LTD, approved on 2022-08-04, with the number SIN16472P. The forensic classification is Prescription Only, and ATC code is L01XG01.
Permalink: https://www.medicinesg.com/sg/meds/bortezomib-kabi-powder-for-solution-for-injection-3-5mg-vial/
- Licence number: SIN16472P
- Product name: BORTEZOMIB KABI POWDER FOR SOLUTION FOR INJECTION 3.5MG/VIAL
- License holder: FRESENIUS KABI (SINGAPORE) PTE LTD
- Approval date: 2022-08-04
- Forensic classification: Prescription Only
- ATC Code: L01XG01
- Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route of Administration: SUBCUTANEOUS or INTRAVENOUS BOLUS
- Manufacturer & Country of manufacturer:
- Active ingredients & Strength: